Improving Cancer Immunotherapy
The Cancer Immunotherapy Consortium of the Cancer Research Institute and the Association for Cancer Immunotherapy published a joint paper in the October 13 issue of Nature Biotechnology, which outlined a comprehensive roadmap that seeks to help improve the development of immunotherapy for Cancer treatment.
Cancer immunotherapy is an option to safely train the immune system of the patient so that they can fight their tumors. Immunotherapy is a powerful treatment that has changed the way doctors and patients look at cancer. While the treatments have not been successful yet on a large scale, partly because of inadequate guidelines and systems to review the treatment. Because of this Cancer immunotherapy has been a difficult undertaking with some negative undertones in the industry, including decreased investor backing and the wariness of the industry to take part in the therapies.
Cancer drug development has evolved slowly over the past fifty years to test anti-cancer treatments and evaluate their success rate. The framework was mainly based on observations of chemotherapeutic agents, which directly target tumor cells. Industry insiders have learned in recent years, however, that immunotherapy can target the immune system and have anti-tumor effects indirectly, making them very different from chemotherapy. They are different in how they work, how long they take to be effective, and the side effects and sustained responses that they induce in the patient. These differences have made it hard for experts to gauge the overall effectiveness of immunotherapy in cancer patients.
According to Axel Hoos, M.D., PhD, the co-chairman of the Cancer Immunotherapy Consortium Executive Committee and primary author of the study, ıAs the scientific understanding of cancer immunology has evolved over the past few decades, it has become necessary, in tandem, to revise the clinical methods used for immunotherapy development. The new framework provides the missing link between scientific knowledge and clinical development and outlines an improved development path for cancer immunotherapies.ı
This health news update is sponsored by PMG Agency. We provide quality Indiana health insurance plans with features designed to work with your life. Contact us and weıll help match you with a plan that doesnıt break the bank. Call (866) 764-2204 to speak with a health insurance advisor.
